Patients with endogenous depression fulfilling Feighner's criteria were included in the trial. All had pretrial scores above 20 on Hamilton's depression rating scale.
With the introduction of new antidepressants and with different symptom complexes responding to different drugs, it is becoming increasingly difficult to choose the right anti-depressant for a particular patient. Various attempts have been made to find out predictors for response to antidepressants.
Clinical, biochemical and pharmacological predictors have been Studied. Only a few studies of response prediction have appeared in the literature . Low baseline urinary excretion of 3 MHPG in depressives have been associated with good response to damphetamine and to imipramine . The response with a one to two day trial of d-amphetamine has been noted to be a good predictor of response to imipramine and desipramine (Fawcett et al. 1971) .
Although d-amphetamine is known to be a central nervous system stimulant, there is a wide variation in individual responses (Lasagna efal, 1953 , Tecce & Cole 1974 , von Kammen & Murphy, 1975 . If a one to two day administration of damphetamine can predict responses to antidepressants which may otherwise require a 3 to 6 week trial, a more rational psychopharmacological approach to the treatment of depression could result rather than present day trial and error (Klein and Davis, 1969) .
This study is an attempt to evaluate the usefulness of a three day trial of damphetamine as a predictor for response to tricyclic antidepressants and also to find out whether there is selective prediction for imipramine and amitriptyline.
MATERIAL AND METHOD
Subjects : Initially 17 patients (14 males, and 3 females) with endogenous depression fulfilling criteria of Feighner et al. (1978) for primary depression, in addition, one of the following were included in the trial :
(a) Family history of depression (b) History of previous attack of depression {c) Early morning insomnia (d) Diurnal variation of mood. All had scores above 20 on Hamilton Depression Rating Scale. None of them had been on any treatment prior to the trial. Their ages ranged from 22 to 52 yrs. All were admitted as inpatients at NIMHANS, Bangalore. During the first two days of their stay they were given 1 Paper presented at the 32nd Annual Conference of the Indian Psychiatric Society, Dec. 1979, • Lecturer in Psychiatry, SRTR Medical College Hospital, Ambajogai, Maharastra.
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• Professor of Psychiatry 8c Medical Superintendent, NIMHANS. placebo and investigated. Two of them showed remarkable improvement and were hence excluded from the study. One patient developed severe stereotype after starting on trial drug, and was excluded. Thus 14 patients were taken for the study.
Administration of drugs :
Drugs were divided into Groups A and B. Group A comprised of placebo and d-amphetamine (7.5 mg per capsule). Group B comprised of imipramine and amitriptyline. Patients were initially started on Group A drugs for the first three days, in a double blind manner. They were given 1 cap. at 8 a.m. and one at 2 p.m. For the next four weeks Group B drugs were given (double-blind) with graded increase in dosage starring from 75 mg to 225 mg. (1st week, 1 cap. h.s., 2nd week, 2 h.s., 3rd and 4th weeks, 3 h.s.).
Evaluation of Treatment :
Patients were rated on Hamilton Depression Rating Scale at the beginning of the trial, on the 1st and 3rd day of Group A use, and 2 weeks and 4 weeks after beginning Group B. Ratings on all occasions were done between 9 and 10 a.m.
Criteria for evaluating response :
50% reduction from the initial score was considered as good response. In evaluating response to Group A, 50% reduction in partial score (4 items on Hamilton Depression Rating Scale HDRS comprising depressed mood, work and interest, retardation, agitation) was used.
RESULTS
Fisher's Exact Probability test was used for finding statistical significance.
When Hamilton Depression Rating Scale was used to evaluate there was improvement in two of fourteen patients (Table 1) . On the third day the same results were obtained.
On evaluation with partial scoring, i.e., on four items of HDRS as already mentioned-(1) 1st day observation showed same results as with evaluation on all items of HDRS (Table 3) . (2) 3rd day observation showed improvement in 6 out of 8 patients who had been given d-amphetamine. This was statistically significant as compared to group A placebo (Table  4 ). All patients who improved with damphetamine also improved with tricyclics. The two who did not improve with damphetamine did not improve with tricyclics. (Table 5 ). 
DISCUSSION
We found significant association, between response to d-amphetame and tricyclics when improvement was evaluated with partial scores. These results are consistent with the study of Fawcett and Siomopoulos (1971) and Von Kammen and Murphy (1978) . Their studies also had limitations because of the small number of subjects.
Amphetamines have been used in the treatment of depression although their efficacy has not been consistently demonstrated. Amphetamine may have unpleasant sideeffects, irritability, loss of sleep which may make the assessment of anti-depressant effect more complex.
This study shows the d-amphetamine can be used as a predictor for response to tricyclics.
Selective prediction for imipramine or amitriptyline was not seen.
